Business
Correction - Notice of Results
Correction - Notice of Results.
About this update from Sareum Holdings Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 8007P\n Sareum Holdings PLC\n 21 October 2021\n \n \n \n \n Correction - Correct Investor Meet Registration Link Included\n \n \n SAREUM HOLDINGS PLC\n \n \n (\"Sareum\" or the \"Company\") \n \n Notice of Final Results for the Year Ended 30 June 2021 and Investor Presentation\n \n Cambridge, UK, 21 October 2021 - Sareum Holdings plc (AIM: SAR), the specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases, will announce its results for the year ended 30 June 2021 on Monday, 25 October 2021.\n The Company will be holding a presentation to investors on Tuesday, 2 November 2021 at 11.00 a.m. via the Investor Meet Company (\"IMC\") platform.\n The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9.00 a.m. the day before the meeting or at any time during the live presentation. Although the Company may not be able to answer every question it receives, it will seek to address the most prominent questions within the confines of information already disclosed to the market. Responses from the Q&A session will be published at the earliest opportunity on the IMC platform.\n Investors can sign up to Investor Meet Company for free and add to meet SAREUM HOLDINGS PLC via:\n \n https://www.investormeetcompany.com/sareum-holdings-plc/register-investor\n \n \n Investors who already follow SAREUM HOLDINGS PLC on the Investor Meet Company platform will automatically be invited.\n \n A copy of the presentation will be made available on the Company's website following the presentation.\n For further information, please contact: \n \n \n \n \n Sareum Holdings plc\n \n \n Tim Mitchell, CEO\n \n \n \n \n \n \n \n \n \n \n 01223 497 700\n \n \n \n \n \n \n Strand Hanson Limited (Nominated Adviser)\n \n \n James Dance / James Bellman\n \n \n \n \n \n \n \n \n \n \n 020 7409 3494\n \n \n \n \n \n \n Hybridan LLP (Nominated Broker)\n \n \n Claire Noyce \n \n \n \n \n \n \n \n \n \n \n 020 3764 2341\n \n \n \n \n \n \n MEDiSTRAVA Consulting (Financial PR)\n \n \n Mark Swallow / David Dible\n \n \n \n \n \n \n \n 020 7638 9571\n \n \n \n \n About Sareum\n \n Sareum is a spec...